Persistence of parvoviris B19 DNA in synovial membranes of young patients with and without chronic arthropathy

被引:198
作者
Söderlund, M
von Essen, R
Haapasaari, J
Kiistala, U
Kiviluoto, O
Hedman, K
机构
[1] UNIV HELSINKI, HAARTMAN INST,DEPT VIROL, FIN-00014 HELSINKI, FINLAND
[2] RHEUMATISM FDN HOSP, SF-18120 HEINOLA, FINLAND
[3] CENT MIL HOSP, HELSINKI, FINLAND
关键词
D O I
10.1016/S0140-6736(96)09110-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Human parvovirus B19 replicates in erythroid precursors of the bone marrow, and several diseases have been attributed to this virus including some cases of juvenile chronic arthropathy. Methods Tissue samples from children with juvenile arthritis and from healthy young adults with recent joint trauma were examined for B19 DNA by PCR. We also studied the timing of the parvovirus infection serologically. Findings All samples of synovial fluid, bone marrow, and blood were negative for B19 DNA. Eight (28%) of the 29 children with chronic arthritis had B19 DNA in synovial tissue. However, an even higher proportion of the non-arthropathy controls were positive for B19 DNA in synovial membranes (13 [48%] of 27). All the individuals with B19 DNA in synovial membrane had serum IgG antibodies to B19. Interpretation Genomic B19 DNA can persist in the synovial membranes not only in patients with chronic arthropathy but also in healthy immunocompetent individuals. The diagnostic criteria for parvovirus arthropathy must be reevaluated.
引用
收藏
页码:1063 / 1065
页数:3
相关论文
共 24 条
[1]   OCCURRENCE OF INFECTION WITH A PARVOVIRUS-LIKE AGENT IN CHILDREN WITH SICKLE-CELL-ANEMIA DURING A 2-YEAR PERIOD [J].
ANDERSON, MJ ;
DAVIS, LR ;
HODGSON, J ;
JONES, SE ;
MURTAZA, L ;
PATTISON, JR ;
STROUD, CE ;
WHITE, JM .
JOURNAL OF CLINICAL PATHOLOGY, 1982, 35 (07) :744-749
[2]   ANTIGENIC PARVOVIRUS B19 COAT PROTEINS VP1 AND VP2 PRODUCED IN LARGE QUANTITIES IN A BACULOVIRUS EXPRESSION SYSTEM [J].
BROWN, CS ;
SALIMANS, MMM ;
NOTEBORN, MHM ;
WEILAND, HT .
VIRUS RESEARCH, 1990, 15 (03) :197-211
[3]   ERYTHROCYTE-P ANTIGEN - CELLULAR RECEPTOR FOR B19 PARVOVIRUS [J].
BROWN, KE ;
ANDERSON, SM ;
YOUNG, NS .
SCIENCE, 1993, 262 (5130) :114-117
[4]   HUMAN PARVOVIRUS B19 DNA IN SYNOVIAL-FLUID [J].
DIJKMANS, BAC ;
VANELSACKERNIELE, AMW ;
SALIMANS, MMM ;
VANALBADAKUIPERS, GA ;
DEVRIES, E ;
WEILAND, HT .
ARTHRITIS AND RHEUMATISM, 1988, 31 (02) :279-281
[5]  
EDWARDS JCW, 1994, J ANAT, V184, P493
[6]   PARVOVIRUS B19 SPECIFIC DNA IN BONE-MARROW FROM B19 ARTHROPATHY PATIENTS - EVIDENCE FOR B19 VIRUS PERSISTENCE [J].
FOTO, F ;
SAAG, KG ;
SCHAROSCH, LL ;
HOWARD, EJ ;
NAIDES, SJ .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) :744-748
[7]   IgG subclass response to human parvovirus B19 infection [J].
Franssila, R ;
Soderlund, M ;
Brown, CS ;
Spaan, WJM ;
Seppala, I ;
Hedman, K .
CLINICAL AND DIAGNOSTIC VIROLOGY, 1996, 6 (01) :41-49
[8]  
Hedman K., 1993, REV MED MICROBIOL, V4, P123, DOI DOI 10.1111/J.1469-0691.1996.TB00196.X
[9]  
KERR JR, 1995, BRIT J RHEUMATOL, V34, P809
[10]   SITE-SPECIFIC INTEGRATION BY ADENOASSOCIATED VIRUS [J].
KOTIN, RM ;
SINISCALCO, M ;
SAMULSKI, RJ ;
ZHU, XD ;
HUNTER, L ;
LAUGHLIN, CA ;
MCLAUGHLIN, S ;
MUZYCZKA, N ;
ROCCHI, M ;
BERNS, KI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2211-2215